Hormone replacement therapy in breast cancer patients and survivors

Giuseppe Del Priore, Mehrangiz Hatami

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Menopause is arguably the most important phase of a woman's social, physiologic, and personal life. Approximately 1.3 million women reach this age in the United States annually. In the past decade, numerous studies have correlated breast cancer and the use of ERT (estrogen replacement therapy) or HRT (hormone replacement therapy) in menopausal women. Whether this is an actual increase in the creation of new cancers or a result of a diagnostic or other bias has yet to be determined. Even more uncertainty surrounds the use of hormones once breast cancer is diagnosed. Previously, once a woman was diagnosed with an estrogen-dependent tumor, ERT and HRT were simply forbidden. As discussed herein, that is no longer the case.

Original languageEnglish (US)
Pages (from-to)165-169
Number of pages5
JournalCurrent Women's Health Reports
Volume3
Issue number2
StatePublished - Apr 2003
Externally publishedYes

Fingerprint

Hormone Replacement Therapy
Survivors
Breast Neoplasms
Estrogen Replacement Therapy
Menopause
Uncertainty
Neoplasms
Estrogens
Hormones

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Hormone replacement therapy in breast cancer patients and survivors. / Del Priore, Giuseppe; Hatami, Mehrangiz.

In: Current Women's Health Reports, Vol. 3, No. 2, 04.2003, p. 165-169.

Research output: Contribution to journalArticle

Del Priore, G & Hatami, M 2003, 'Hormone replacement therapy in breast cancer patients and survivors', Current Women's Health Reports, vol. 3, no. 2, pp. 165-169.
Del Priore, Giuseppe ; Hatami, Mehrangiz. / Hormone replacement therapy in breast cancer patients and survivors. In: Current Women's Health Reports. 2003 ; Vol. 3, No. 2. pp. 165-169.
@article{d2f844e60ae941f4aefa5b8fbe724d9e,
title = "Hormone replacement therapy in breast cancer patients and survivors",
abstract = "Menopause is arguably the most important phase of a woman's social, physiologic, and personal life. Approximately 1.3 million women reach this age in the United States annually. In the past decade, numerous studies have correlated breast cancer and the use of ERT (estrogen replacement therapy) or HRT (hormone replacement therapy) in menopausal women. Whether this is an actual increase in the creation of new cancers or a result of a diagnostic or other bias has yet to be determined. Even more uncertainty surrounds the use of hormones once breast cancer is diagnosed. Previously, once a woman was diagnosed with an estrogen-dependent tumor, ERT and HRT were simply forbidden. As discussed herein, that is no longer the case.",
author = "{Del Priore}, Giuseppe and Mehrangiz Hatami",
year = "2003",
month = "4",
language = "English (US)",
volume = "3",
pages = "165--169",
journal = "Current Women's Health Reports",
issn = "1534-5874",
publisher = "Current Science, Inc.",
number = "2",

}

TY - JOUR

T1 - Hormone replacement therapy in breast cancer patients and survivors

AU - Del Priore, Giuseppe

AU - Hatami, Mehrangiz

PY - 2003/4

Y1 - 2003/4

N2 - Menopause is arguably the most important phase of a woman's social, physiologic, and personal life. Approximately 1.3 million women reach this age in the United States annually. In the past decade, numerous studies have correlated breast cancer and the use of ERT (estrogen replacement therapy) or HRT (hormone replacement therapy) in menopausal women. Whether this is an actual increase in the creation of new cancers or a result of a diagnostic or other bias has yet to be determined. Even more uncertainty surrounds the use of hormones once breast cancer is diagnosed. Previously, once a woman was diagnosed with an estrogen-dependent tumor, ERT and HRT were simply forbidden. As discussed herein, that is no longer the case.

AB - Menopause is arguably the most important phase of a woman's social, physiologic, and personal life. Approximately 1.3 million women reach this age in the United States annually. In the past decade, numerous studies have correlated breast cancer and the use of ERT (estrogen replacement therapy) or HRT (hormone replacement therapy) in menopausal women. Whether this is an actual increase in the creation of new cancers or a result of a diagnostic or other bias has yet to be determined. Even more uncertainty surrounds the use of hormones once breast cancer is diagnosed. Previously, once a woman was diagnosed with an estrogen-dependent tumor, ERT and HRT were simply forbidden. As discussed herein, that is no longer the case.

UR - http://www.scopus.com/inward/record.url?scp=0037665965&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037665965&partnerID=8YFLogxK

M3 - Article

C2 - 12628087

AN - SCOPUS:0037665965

VL - 3

SP - 165

EP - 169

JO - Current Women's Health Reports

JF - Current Women's Health Reports

SN - 1534-5874

IS - 2

ER -